CareDx, Inc.: updates and filings

CDNANASDAQHealthcare · Services-Medical Laboratories

Price

$74.56

November 17, 2026Market cap $3.8B

What Ploutos Investor adds for CareDx

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 14 fiscal years, from 2012
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 73 daysAround Jan 29, 2027 · for Q4 2026

last Oct 29, 2026next Jan 29, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 25, 2026 latest annualOct 29, 2026 latest quarterly
  • Nov 10, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Oct 29, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Oct 29, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Sep 16, 2026Acquisition or disposal of assets (amendment)
    Form8-K/A
  • Aug 14, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 7, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 7, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Jul 30, 2026Shares registered for employees
    FormS-8
  • Jul 30, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Jul 30, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Jul 27, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jul 7, 2026Acquisition or disposal of assets, Regulation FD disclosure
    Form8-K
  • Jun 15, 2026Officer or director change, shareholder vote
    Form8-K
  • Jun 5, 2026Additional annual meeting material
    FormDEFA14A
  • Apr 28, 2026Shelf registration for future offerings
    FormS-3ASR
  • Apr 28, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • Apr 28, 2026Material agreement entered, results of operations, Regulation FD disclosure, other material events
    Form8-K
  • Apr 27, 2026Annual report to shareholdersfor the period to Dec 31, 2025
    FormARS
  • Apr 27, 2026Additional annual meeting material
    FormDEFA14A
  • Apr 27, 2026Annual meeting proxy statement
    FormDEF 14A
  • Apr 23, 2026Officer or director change (amendment)
    Form8-K/A
  • Apr 16, 2026Material agreement entered, results of operations, Regulation FD disclosure
    Form8-K
  • Mar 26, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Feb 25, 2026Results of operations, officer or director change, Regulation FD disclosure (amendment)
    Form8-K/A
  • Feb 25, 2026Annual reportfor the period to Dec 31, 2025
    Form10-K

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jan 31, 2003.

The full analysis

What do CareDx's filings show?

The filings are where every one of CareDx's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.